Ultragenyx Pharmaceutical (RARE) Q3 2021 Earnings

2AugConfirmed
Q4 2020
Q1 2021
Q2 2021
Q3 2021
-2.03
-1.48
-0.92
-0.37

Details

Expected EPS
-1.4
Actual EPS
-1.81
Surprise EPS
-0.41
Surprise Percent
+29.29%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.81 per share for Q3 2021.

0 Comments

Share your thoughts